STRATEC Biomedical AG / Key word(s): Dividend
STRATEC adopts dividend proposal for 2013 financial year
Birkenfeld, April 25, 2014
The Board of Management and Supervisory Board of STRATEC Biomedical AG (Frankfurt: SBS; Prime Standard, TecDAX) will be proposing the distribution of a dividend of EUR 0.60 per share with dividend rights for the 2013 financial year for approval by the Annual General Meeting on June 18, 2014 (distribution in 2013 for the 2012 financial year: EUR 0.56). At its meeting today, the Supervisory Board endorsed the corresponding recommendation submitted by the Board of Management. Subject to approval by the Annual General Meeting, shareholders can expect to benefit from the tenth dividend increase in succession since the first dividend payment in 2004.
Further information can be obtained from:
End of Corporate News
25.04.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
|Company:||STRATEC Biomedical AG|
|Phone:||+49 (0)7082 7916 0|
|Fax:||+49 (0)7082 7916 999|
|Listed:||Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, München, Stuttgart|
|End of News||DGAP News-Service|